## Abstract mAb proteomics, a reversed biomarker discovery approach, is a novel methodology to recognize the proteins of biomarker potential, but requires subsequent antigen identification steps. While in case of highβabundant proteins, it generally does not represent a problem, for medium or lower
Plasma proteomics for biomarker discovery: A study in blue
β Scribed by Francesco Di Girolamo; Pier Giorgio Righetti
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 573 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0173-0835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
There is an increasing interest in the discovery of new inflammatory bowel disease (IBD) biomarkers able to predict the future patterns of disease and to help in diagnosis, treatment, and prognosis. A biomarker is a substance that can be measured biologically and is associated with an increased risk
## Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery A compelling need exists for the development of technologies that facilitate and accelerate the discovery of novel protein biomarkers with therapeutic and diagnostic potential. The inherent disadvant